Vaccine storage issues could leave 3B people without access
The chain breaks here, in a tiny medical clinic in Burkina Faso that went nearly a year without a working refrigerator.
Oct 19, 2020
0
0
The chain breaks here, in a tiny medical clinic in Burkina Faso that went nearly a year without a working refrigerator.
Oct 19, 2020
0
0
Dozens of companies, from biotech start-ups to Big Pharma, are racing to develop a safe and effective COVID-19 vaccine, because the world needs it and for the potential pay day.
Oct 16, 2020
0
29
A Chinese COVID-19 vaccine candidate based on the inactivated whole SARS-CoV-2 virus (BBIBP-CorV) is safe and elicits an antibody response, findings from a small early-phase randomised clinical trial published today in The ...
Oct 16, 2020
1
524
A COVID-19 vaccine candidate that underwent extensive preclinical testing at the University of Alabama at Birmingham this spring and summer shows potent preclinical immune responses—including several that distinguish it ...
Oct 13, 2020
0
5
Johnson & Johnson said Monday it had temporarily halted its COVID-19 vaccine trial because one of its participants had become sick.
Oct 13, 2020
0
3
China, which has at least four coronavirus vaccine candidates in the last stage of clinical trials, said Friday it is joining an international initiative to distribute COVID-19 vaccines to countries worldwide known as COVAX, ...
Oct 9, 2020
0
3
Swiss authorities said Tuesday they had begun assessing AstraZeneca and Oxford University's COVID-19 vaccine—the first such treatment submitted for authorisation in the country.
Oct 6, 2020
0
5
The White House has blocked new Food and Drug Administration guidelines on bringing potential vaccines for COVID-19 to market that would almost certainly have prevented their approval before the Nov. 3 election.
Oct 6, 2020
0
2
The grim milestone of one million COVID-19 deaths should spur the planet into fighting back against the disease, the WHO insisted Tuesday, saying it was "never too late to turn things around".
Sep 29, 2020
0
0
A new precision drug which stops cancer from repairing its DNA has shown promise in an early-stage clinical trial—highlighting the potential of a new class of drugs known as ATR inhibitors.
Sep 29, 2020
0
95